You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Intraparenchymal chordoid Meningioma After Radiotherapy for Hodgkin Lymphoma: A Case Report and Review of the Literatur
Contributor:
Mustafa Efendioglu;
Recep Basaran;
Dogan Gundogan;
Fatih Han Bolukbasi;
Mustafa Kaksi;
Aydin Sav;
Tuncay Kaner
imprint:
Neoplasia Research, 2014
Published in:Journal of Cancer Research Updates
Language:
Not determined
DOI:
10.6000/1929-2279.2014.03.01.4
ISSN:
1929-2279
Origination:
Footnote:
Description:
<jats:p>Objective: Hodgkin lymphoma can be treated by radiotherapy or chemotherapy alone or combined. Meningiomas account for 1-4.2% of all primary intracranial tumors in children, and chordoid meningioma is a very rare subtype. In this study, we investigated a case of an intraparenchymal chordoid meningioma that developed during the early stage in a patient with Hodgkin lymphoma who had been treated with radiotherapy.
Case: A 10-year-old male patient was diagnosed with Hodgkin lymphoma and was treated with a combination of radiotherapy and chemotherapy. He presented at our emergency service 6 years later. He had a fever and was suffering from discomfort and insignificant left hemiparesis (4/5). Contrast-enhanced cranial magnetic resonance imaging (MRI) showed a mass in the right temporoparietal region. The intracranial lesion was surgically excised. The tumor was identified as a WHO grade 2 chordoid meningioma by the pathological examination. The Ki-67 proliferation index was found to be 20-25%.
Conclusion: Surgeons must remember that radiation-associated meningiomas may occur in the early stage of the treatment as well as in the late stage. Young patients with grade 2 chordoid meningiomas must be followed-up in case of recurrence, and tumors with high Ki-67 indexes are highly expected to relapse.</jats:p>